Venture Incubator Partners

VI Partners (Venture Incubator Partners AG) is a prominent Swiss venture capital firm founded in 2001 by McKinsey & Company and ETH Zurich. The firm was established with the support of ten leading Swiss corporations, including Novartis, Nestlé, and ABB, to foster innovation and support high-tech spin-offs. VI Partners specializes in early-stage investments in the life sciences, information technology, and physical sciences sectors, primarily within Switzerland and Europe. In the healthcare domain, the firm targets breakthrough innovations in biotechnology, medical devices, and diagnostics. Notable portfolio companies include Xeltis, Anaveon, and Artios Pharma, reflecting a strong focus on oncology and cardiovascular restoration. Headquartered in Altendorf, Switzerland, VI Partners provides both capital and strategic expertise to help entrepreneurs transition academic research into commercially viable enterprises.